|
Volumn 3, Issue 10, 2012, Pages 1275-1281
|
A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
OXALIPLATIN;
PROTEIN P53;
TEXAPHYRIN;
TEXAPHYRIN OXALIPLATIN CONJUGATE;
UNCLASSIFIED DRUG;
APOPTOSIS;
ARTICLE;
CANCER CELL;
CANCER RESISTANCE;
CONTROLLED STUDY;
DNA ADDUCT;
DRUG CYTOTOXICITY;
DRUG DESIGN;
FEMALE;
HUMAN;
HUMAN CELL;
IC 50;
PRIORITY JOURNAL;
R FACTOR;
|
EID: 84867028392
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c2md20206a Document Type: Article |
Times cited : (28)
|
References (37)
|